Postinfarction ventricular tachycardia and fibrillation: reassessing the role of drug therapy and approach to the high risk patient.
Peter
C T
CT
Helfant
R H
RH
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications*; D012307:Risk Factors; D013610:Tachycardia / Q000188:drug therapy* / Q000209:etiology; D014693:Ventricular Fibrillation / Q000188:drug therapy* / Q000209:etiology
D000889:Anti-Arrhythmia Agents